Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial

A systematic review of pre-operative anaemia and blood transfusion in patients with fractured hips

(2015) L. J. Potter et al.   ANAESTHESIA

Blood Transfusion and Overall Quality of Life After Hip Fracture in Frail Elderly Patients—The Transfusion Requirements in Frail Elderly Randomized Controlled Trial

(2015) Merete Gregersen et al.   Journal of the American Medical Directors Association

The Safety of Intravenous Iron Preparations

(2015) Tomer Avni et al.   MAYO CLINIC PROCEEDINGS

Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis

(2015) L. B. Holst et al.   BMJ-British Medical Journal

Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis

(2015) L. B. Holst et al.   BMJ-British Medical Journal

Early surgery for patients with a fracture of the hip decreases 30-day mortality

(2015) C. P. Bretherton et al.   Bone & Joint Journal

Recovery of health-related quality of life in a United Kingdom hip fracture population

(2015) X. L. Griffin et al.   Bone & Joint Journal

Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty

(2014) E. Bisbe et al.   BRITISH JOURNAL OF ANAESTHESIA

Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery

(2014) E. Rineau et al.   BRITISH JOURNAL OF ANAESTHESIA

Preoperative Erythropoietin Alpha Reduces Postoperative Transfusions in THA and TKA but May Not Be Cost-effective

(2014) Hany Bedair et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Evolution of the hip fracture population: time to consider the future? A retrospective observational analysis

(2014) Paul N Baker et al.   BMJ Open

Potential Cost Saving of Epoetin alfa in Elective Hip or Knee Surgery due to Reduction in Blood Transfusions and Their Side Effects: A Discrete-Event Simulation Model

(2013) Jörg Tomeczkowski et al.   PLoS One

Efficacy and Safety of Erythropoietin and Intravenous Iron in Perioperative Blood Management: A Systematic Review

(2013) David M. Lin et al.   TRANSFUSION MEDICINE REVIEWS

The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial

(2013) Martin Rowlands et al.   Trials

Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials

(2013) E. Litton et al.   BMJ-British Medical Journal

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

Emerging topics in anaemia and cancer

(2012) M. Aapro   ANNALS OF ONCOLOGY

Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

(2012) Máximo Bernabeu-Wittel et al.   BMC MUSCULOSKELETAL DISORDERS

More than half of hip fracture patients do not regain mobility in the first postoperative year

(2012) Anne JH Vochteloo et al.   Geriatrics & Gerontology International

Hierro intravenoso preoperatorio como estrategia de ahorro de sangre en cirugía de fractura de cadera

(2012) Nieves Blanco Rubio et al.   MEDICINA CLINICA

The risks of red cell transfusion for hip fracture surgery in the elderly

(2012) A. Shokoohi et al.   VOX SANGUINIS

An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic

(2012) Paul D. Wilson et al.   JOURNAL OF MEDICAL ECONOMICS

Efficacy and Safety of Iron Supplementation for the Elderly Patients Undergoing Hip or Knee Surgery: A Meta-Analysis of Randomized Controlled Trials

(2011) Yuehua Yang et al.   JOURNAL OF SURGICAL RESEARCH

Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery

(2011) Jeffrey L. Carson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integrated strategies for allogeneic blood saving in major elective surgery

(2011) Maria Beatrice Rondinelli et al.   TRANSFUSION AND APHERESIS SCIENCE

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty (CME)

(2010) Hyo-Seok Na et al.   TRANSFUSION

Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial

(2010) José Antonio Serrano-Trenas et al.   TRANSFUSION

Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression

(2009) Toshiya Shiga et al.   Canadian Journal of Anesthesia-Journal canadien d anesthesie

Ferric Carboxymaltose

(2009) Katherine A. Lyseng-Williamson et al.   DRUGS

Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture

(2009) Konstantinos Kateros et al.   JOURNAL OF CRITICAL CARE

Use of agents stimulating erythropoiesis in digestive diseases

(2009) Rosario Moreno López et al.   WORLD JOURNAL OF GASTROENTEROLOGY

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial

(2008) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia

(2008) Christian Breymann et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Epidemiology of hip fracture in the elderly in Spain

(2007) M. Loreto Alvarez-Nebreda et al.   BONE